BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 37259854)

  • 1. Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation.
    Mehata AK; Vikas ; Viswanadh MK; Muthu MS
    Nanomedicine (Lond); 2023 Apr; 18(8):695-703. PubMed ID: 37259854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimuli-Responsive Design of Metal-Organic Frameworks for Cancer Theranostics: Current Challenges and Future Perspective.
    Pantwalawalkar J; Mhettar P; Nangare S; Mali R; Ghule A; Patil P; Mohite S; More H; Jadhav N
    ACS Biomater Sci Eng; 2023 Aug; 9(8):4497-4526. PubMed ID: 37526605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineering of Metal-organic Frameworks for Nanomedicine.
    Liu Y; Zhao Y; Chen X
    Theranostics; 2019; 9(11):3122-3133. PubMed ID: 31244945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
    Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
    Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoscaled Metal-Organic Frameworks for Biosensing, Imaging, and Cancer Therapy.
    Zhou J; Tian G; Zeng L; Song X; Bian XW
    Adv Healthc Mater; 2018 May; 7(10):e1800022. PubMed ID: 29508557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling metal organic frameworks with molybdenum disulfide nanoflakes for targeted cancer theranostics.
    Yang S; Li D; Chen L; Zhou X; Fu L; You Y; You Z; Kang L; Li M; He C
    Biomater Sci; 2021 May; 9(9):3306-3318. PubMed ID: 33459315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale metal-organic frameworks as key players in the context of drug delivery: evolution toward theranostic platforms.
    Carrillo-Carrión C
    Anal Bioanal Chem; 2020 Jan; 412(1):37-54. PubMed ID: 31734711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and emerging applications of nanostructured metal-organic frameworks in cancer-targeted theranostics.
    Lakshmi BA; Kim S
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110091. PubMed ID: 31546428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in antitumor nanomedicine based on functional metal-organic frameworks beyond drug carriers.
    Wei Q; Wu Y; Liu F; Cao J; Liu J
    J Mater Chem B; 2022 Feb; 10(5):676-699. PubMed ID: 35043825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
    Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
    Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal-Organic Framework (MOF)-Based Drug/Cargo Delivery and Cancer Therapy.
    Wu MX; Yang YW
    Adv Mater; 2017 Jun; 29(23):. PubMed ID: 28370555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal-Organic Framework-Based Nanomedicine Platforms for Drug Delivery and Molecular Imaging.
    Cai W; Chu CC; Liu G; Wáng YX
    Small; 2015 Oct; 11(37):4806-22. PubMed ID: 26193176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal-Organic Framework Nanoparticle-Based Biomineralization: A New Strategy toward Cancer Treatment.
    Chu C; Su M; Zhu J; Li D; Cheng H; Chen X; Liu G
    Theranostics; 2019; 9(11):3134-3149. PubMed ID: 31244946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy.
    He L; Liu Y; Lau J; Fan W; Li Q; Zhang C; Huang P; Chen X
    Nanomedicine (Lond); 2019 May; 14(10):1343-1365. PubMed ID: 31084393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoporous metal organic frameworks as hybrid polymer-metal composites for drug delivery and biomedical applications.
    Beg S; Rahman M; Jain A; Saini S; Midoux P; Pichon C; Ahmad FJ; Akhter S
    Drug Discov Today; 2017 Apr; 22(4):625-637. PubMed ID: 27742533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal organic frameworks (MOFs) with therapeutic and biomedical applications: a patent review.
    Teixeira de Alencar Filho JM; Sampaio PA; Silva de Carvalho I; Rocha da Silva A; Pereira ECV; Araujo E Amariz I; Nishimura RHV; Cavalcante da Cruz Araújo E; Rolim-Neto PJ; Rolim LA
    Expert Opin Ther Pat; 2021 Oct; 31(10):937-949. PubMed ID: 33915072
    [No Abstract]   [Full Text] [Related]  

  • 17. Metal-organic frameworks (MOFs) as effectual diagnostic and therapeutic tools for cancer.
    Gulati S; Choudhury A; Mohan G; Katiyar R; Kurikkal M P MA; Kumar S; Varma RS
    J Mater Chem B; 2023 Jul; 11(29):6782-6801. PubMed ID: 37377082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
    Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
    Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering Phototheranostic Nanoscale Metal-Organic Frameworks for Multimodal Imaging-Guided Cancer Therapy.
    Cai W; Gao H; Chu C; Wang X; Wang J; Zhang P; Lin G; Li W; Liu G; Chen X
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2040-2051. PubMed ID: 28032505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoscale MOFs: From synthesis to drug delivery and theranostics applications.
    Ding M; Liu W; Gref R
    Adv Drug Deliv Rev; 2022 Nov; 190():114496. PubMed ID: 35970275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.